Positive Airway Pressure Adherence and Health Care Resource Utilization in Patients With Obstructive Sleep Apnea and Heart Failure With Reduced Ejection Fraction
Authors:
- Kate V. ColeKCKate V. Cole
- Anita S. MalikAMAnita S. Malik
- Fatima H. Sert KuniyoshiFKFatima H. Sert Kuniyoshi
- Peter A. CistulliPCPeter A. Cistulli
- Virend K. SomersVSVirend K. Somers
- Peter CistulliPCPeter Cistulli
- Kimberly L. SterlingKSKimberly L. Sterling
- Carlos M. NunezCNCarlos M. Nunez
- Meredith BarrettMBMeredith Barrett
- 16 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (10) , e028732
Abstract
Background: Obstructive sleep apnea (OSA) is a common comorbidity in patients with heart failure, although current evidence is equivocal regarding the potential benefits of treating OSA with positive airway pressure (PAP) therapy in patients with heart failure. This study assessed the impact of adherence to PAP therapy on health care resource utilization in patients with OSA and heart failure with reduced ejection fraction. Methods and Results: Administrative insurance claims data linked with objective PAP therapy use data from patients with OSA and heart failure with reduced ejection fraction were used to determine associations between PAP adherence and a composite outcome of hospitalizations and emergency room visits. One‐year PAP adherence was based on an adapted US Medicare definition. Propensity score methods were used to create groups with similar characteristics across PAP adherence levels. The study cohort included 3182 patients (69.9% male, mean age 59.7 years); 39% were considered adherent to PAP therapy (29% intermediate adherent, 31% nonadherent). One year after PAP initiation, adherent patients had fewer composite visits than matched nonadherent patients, driven by a 24% reduction in emergency room visits for adherent patients. Composite visit costs were lower in adherent versus nonadherent patients ($3500 versus $5879, P =0.031), although total health care costs were not statistically different ($13 028 versus $14 729, P =0.889). Conclusions: PAP therapy adherence in patients with OSA with heart failure with reduced ejection fraction was associated with a reduction in health care resource utilization. This suggests that greater emphasis should be placed on diagnosing and effectively treating OSA with PAP in patients with heart failure with reduced ejection fraction.Keywords
This publication has 47 references indexed in Scilit:
- Adherence to Sleep Apnea Therapy and Use of Lipid-Lowering DrugsChest, 2010
- Oxidative Stress—A Unifying Paradigm in Obstructive Sleep Apnea and ComorbiditiesProgress in Cardiovascular Diseases, 2009
- Inflammation, Oxidative Stress, and Repair Capacity of the Vascular Endothelium in Obstructive Sleep ApneaCirculation, 2008
- Influence of Obstructive Sleep Apnea on Mortality in Patients With Heart FailureJACC, 2007
- Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial FibrillationJACC, 2007
- Obstructive Sleep ApneaAnnals of Internal Medicine, 2005
- Obstructive Sleep Apnea and the Recurrence of Atrial FibrillationCirculation, 2003
- Heart FailureNew England Journal of Medicine, 2003
- Cardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep ApneaNew England Journal of Medicine, 2003
- Sleep Apnea in 81 Ambulatory Male Patients With Stable Heart FailureCirculation, 1998